Role of nitric oxide in the regulation of cerebral blood flow in humans: Chemoregulation versus mechanoregulation

Circulation

Volumn 107, Issue 14, 2003, Pages 1901-1905

  Lavi, Shahar ^a   Egbarya, Rania ^a   Lavi, Ronit ^a   Jacob, Giris ^a,b  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b RAMBAM MEDICAL CENTER   (Israel)

Author keywords

Cerebrovascular circulation; Cerebrovascular disorders; Nitric oxide; Receptors, adrenergic, alpha

Indexed keywords

NITRIC OXIDE; NITROPRUSSIDE SODIUM; PHENYLEPHRINE;

ADULT; ARTICLE; BLOOD FLOW VELOCITY; BRAIN BLOOD FLOW; CALCULATION; CARBON DIOXIDE MEASUREMENT; DOPPLER ECHOGRAPHY; DOSE RESPONSE; DRUG INFUSION; FEMALE; HUMAN; HUMAN EXPERIMENT; HYPERVENTILATION; HYPOTHESIS; MALE; MEAN ARTERIAL PRESSURE; NORMAL HUMAN; PRIORITY JOURNAL; VASCULAR RESISTANCE; VASOCONSTRICTION; VASODILATATION;

ADRENERGIC ALPHA-AGONISTS; ADULT; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CEREBROVASCULAR CIRCULATION; FEMALE; HEMODYNAMIC PROCESSES; HOMEOSTASIS; HUMANS; HYPERCAPNIA; HYPOCAPNIA; MALE; MIDDLE CEREBRAL ARTERY; NITRIC OXIDE; NITRIC OXIDE DONORS; NITROPRUSSIDE; PHENYLEPHRINE; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 0037446709     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000057973.99140.5A     Document Type: Article

References (35)

1. Strandgaard S, Paulson OB. Regulation of cerebral blood flow in health and disease. J Cardiovasc Pharmacol. 1992;19(suppl 6):S89-S93.
2. Strandgaard S, Paulson OB. Cerebral autoregulation. Stroke. 1984;15:413-416.
3. Panerai RB, Dawson SL, Eames PJ, et al. Cerebral blood flow velocity response to induced and spontaneous sudden changes in arterial blood pressure. Am J Physiol Heart Circ Physiol. 2001;280:H2162-H2174.
4. Low PA, Novak V, Spies JM, et al. Cerebrovascular regulation in the postural orthostatic tachycardia syndrome (POTS). Am J Med Sci. 1999;317:124-133.
5. Weiss MH, Spence J, Apuzzo ML, et al. Influence of nitroprusside on cerebral pressure autoregulation. Neurosurgery. 1979;4:56-59.
6. Thompson BG, Pluta RM, Girton ME, et al. Nitric oxide mediation of chemoregulation but not autoregulation of cerebral blood flow in primates. J Neurosurg. 1996;84:71-78.
7. Buchanan JE, Phillis JW. The role of nitric oxide in the regulation of cerebral blood flow. Brain Res. 1993;610:248-255.
8. Joshi S. Young WL, Duong DH, et al. Intracarofid infusion of the nitric oxide synthase inhibitor, L-NMMA, modestly decreases cerebral blood flow in human subjects. Anesthesiology. 2000;93:699-707.
9. Schmetterer L, Findl O, Strenn K, et al. Role of NO in the O2 and CO2 responsiveness of cerebral and ocular circulation in humans. Am J Physiol. 1997;273:R2005-R2012.
10. Joshi S, Young WL, Pile-Spellman J, et al. Intra-arterial nitrovasodilators do not increase cerebral blood flow in angiogaphically normal territories of arteriovenous malformation patients. Stroke. 1997;28:1115-1122.
11. Joshi S, Young WL, Duong H, et al. Intracarotid nitroprusside does not augment cerebral blood flow in human subjects. Anesthesiology. 2002;96:60-66.
12. Vajkoczy P, Hubner U, Horn P, et al. Intrathecal sodium nitroprusside improves cerebral blood flow and oxygenation in refractory cerebral vasospasm and ischemia in humans. Stroke. 2000;31:1195-1197.
13. Thomas JE, Rosenwasser RH. Reversal of severe cerebral vasospasm in three patients after aneurysmal subarachnoid hemorrhage: initial observations regarding the use of intraventricular sodium nitroprusside in humans. Neurosurgery. 1999;44:48-57.
14. Barton CW, Wang ES. Correlation of end-tidal CO2 measurements to arterial PaCO2 in nonintubated patients. Ann Emerg Med. 1994;23:560-563.
15. Serrador JM, Picot PA, Rutt BK, et al. MRI measures of middle cerebral artery diameter in conscious humans during simulated orthostasis. Stroke. 2000;31:1672-1678.
16. Chillon JM, Baumbach GL. Autoregulation of cerebral blood flow. In: Welch KMA, Caplan RL, Reis JD, et al, eds. Primer on Cerebrovascular Diseases. New York, NY: Academic Press: 1997:51-54.
17. Traystman RJ. Regulation of cerebral blood flow by carbon dioxide. In: Welch KMA, Caplan RL, Reis JD, et al. eds. Primer on Cerebrovascular Diseases. New York, NY: Academic Press; 1997:55-58.
18. Jordan J, Shannon JR, Diedrich A, et al. Interaction of carbon dioxide and sympathetic nervous system activity in the regulation of cerebral perfusion in humans. Hypertension. 2000;36:383-388.
19. Bevan RD, Dodge J, Nichols P, et al. Weakness of sympathetic neural control of human pial compared with superficial temporal arteries reflects low innervation density and poor sympathetic responsiveness. Stroke. 1998;29:212-221.
20. Novak V, Novak P, Spies JM, et al. Autoregulation of cerebral blood flow in orthostatic hypotension. Stroke. 1998;29:104-111.
21. Jacob G, Robertson D. Orthostatic hypotension: epidemiology, pathophysiology and management. Curr Opin Nephrol Hypertens. 1995;4:452-454.
22. Lee HW, Caldwell JE, Dodson B, et al. The effect of clonidine on cerebral blood flow velocity, carbon dioxide cerebral vasoreactivity, and response to increased arterial pressure in human volunteers. Anesthesiology. 1997;87:553-558.
23. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med. 1993;329:2002-2012.
24. ladecola C, Pelligrino DA, Moskowitz MA, et al. Nitric oxide synthase inhibition and cerebrovascular regulation. J Cereb Blood Flow Metab. 1994;14:175-192.
25. Joshi S, Duong H, Mangla S, et al. In nonhuman primates intracarotid adenosine, but not sodium nitroprusside, increases cerebral blood flow. Anesth Analg. 2002;94:393-399.
26. Aaslid R, Markwalder TM, Nornes H. Noninvasive transcranial Doppler ultrasound recording of flow velocity in basal cerebral arteries. J Neurosurg. 1982;57:769-774.
27. Djurberg HG, Seed RF, Evans DA, et al. Lack of effect of CO2 on cerebral arterial diameter in man. J Clin Anesth. 1998;10:646-651.
28. Burnum JF, Hickam JB, McIntosh HD. The effect of hypocapnia on arterial blood pressure. Circulation. 1954;9:89-95.
29. Onrot J, Bernard GR, Biaggioni I, et al. Direct vasodilator effect of hyperventilation-induced hypocarbia in autonomic failure patients. Am J Med Sci. 1991;301:305-309.
30. White RP, Hindley C, Bloomfield PM, et al. The effect of the nitric oxide synthase inhibitor L-NMMA on basal CBF and vasoneuronal coupling in man: a PET study. J Cereb Blood Flow Metab. 1999;19:673-678.
31. Artru AA. Partial preservation of cerebral vascular responsiveness to hypocapnia during isoflurane-induced hypotension in dogs. Anesth Analg. 1986;65:660-666.
32. Niwa K, Lindauer U, Villringer A, et al. Blockade of nitric oxide synthesis in rats strongly attenuates the CBF response to extracellular acidosis. J Cereb Blood Flow Metab. 1993;13:535-539.
33. Komjati K, Greenberg JH, Reivich M, et al. Interactions between the endothelium-derived relaxing factor/nitric oxide system and the endogenous opiate system in the modulation of cerebral and spinal vascular CO2 responsiveness. J Cereb Blood Flow Metab. 2001;21:937-944.
34. Puscas I, Coltau M, Domuta G, et al. Carbonic anhydrase I inhibition by nitric oxide: implications for mediation of the hypercapnia-induced vasodilator response. Clin Exp Pharmacol Physiol. 2000;27:95-99.
35. Bari F, Errico RA, Louis TM, et al. Interaction between ATP-sensitive K+ channels and nitric oxide on pial arterioles in piglets. J Cereb Blood Flow Metab. 1996;16:1158-1164.